1. Kajino H, Chen YQ, Seidner SR, et al. Factors that
increase the contractile tone of the ductus arteriosus also regulate
its anatomic remodeling. Am J Physiol. 2001;281(1):R291-R301.
2. Sakurai H, Matsuoka R, Furutani Y, Imamura S, Takao A, Momma
K. Expression of four myosin heavy chain genes in developing blood
vessels and other smooth muscle organs in rabbits. Eur J
Cell Biol. 1996;69(2):166-172.
3. Slomp J, Gittenberger-de Groot AC, Glukhova MA, et al. Differentiation,
dedifferentiation, and apoptosis of smooth muscle cells during the development
of the human ductus arteriosus. Arterioscler Thromb Vasc
Biol. 1997;17(5):1003-1009.
4. Colbert MC, Kirby ML, Robbins J. Endogenous retinoic acid
signaling colocalizes with advanced expression of the adult smooth
muscle myosin heavy chain isoform during development of the ductus
arteriosus. Circ Res. 1996;78(5):790-798.
5. Crichton CA, Smith GC, Smith GL. a-Toxin-permeabilised rabbit
fetal ductus arteriosus is more sensitive to Ca
2+ than
aorta or main pulmonary artery.
Cardiovasc Res. 1997;33(1):223–229.
[PubMed: 9059548]
6. Clyman RI, Waleh NS, Kajino H, Roman C, Mauray F. Calcium-dependent
and calcium-sensitizing pathways in the mature and immature ductus
arteriosus. Am J Physiol Regul Integr Comp Physiol. 2007;293(4):R1650-R1656.
7. Coceani F, Liu Y, Seidlitz E, et al. Endothelin A receptor
is necessary for O(2) constriction but not closure of ductus arteriosus. Am
J Physiol. 1999;277(4 Pt 2):H1521-H1531.
8. Tomita H, Fuse S, Chiba S. Catecholamine-induced ductus arteriosus
constriction in children. Am J Cardiol. 1996;77(15):1372-1375.
9. Bergwerff M, DeRuiter MC, Gittenberger-de Groot AC. Comparative
anatomy and ontogeny of the ductus arteriosus, a vascular outsider. Anat
Embryol (Berl). 1999;200(6):559-571.
10. Padbury JF, Polk DH, Newnham JP, Lam RW. Neonatal adaptation:
greater sympathoadrenal response in preterm than full term fetal
sheep at birth. Am J Physiol. 1985;248:E443-E449.
11. Clyman RI, Mauray F, Heymann MA, Roman C. Influence of increased
pulmonary vascular pressures on the closure of the ductus arteriosus in
newborn lambs. Pediatr Res. 1989;25(2):136-142.
12. Momma K, Toyono M. The role of nitric oxide in dilating
the fetal ductus arteriosus in rats. Pediatr Res. 1999;46(3):311-315.
13. Clyman RI, Mauray F, Roman C, Rudolph AM. PGE
2 is
a more potent vasodilator of the lamb ductus arteriosus than either
PGI
2 or 6 keto PGF
1a.
Prostaglandins. 1978;16:259-264.
[PubMed: 360304]
14. Coceani F, Bodach E, White E, Bishai I, Olley PM. Prostaglandin
I2 is less relaxant than prostaglandin E2 on the
lamb ductus arteriosus. Prostaglandins. 1978;15(4):551-556.
15. Bouayad A, Kajino H, Waleh N, et al. Characterization of
PGE(2) receptors in fetal and newborn lamb ductus arteriosus. Am
J Physiol. 2001;280(5):H2342-H2349.
16. Toyoshima K, Momma K, Imamura S, Nakanishi T. In vivo dilatation
of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase
3 in rats. Biol Neonate. 2006;89(4):251-256.
17. Takahashi Y, Roman C, Chemtob S, et al. Cyclooxygenase-2
inhibitors constrict the fetal lamb ductus arteriosus both in vitro
and in vivo. Am J Physiol Regul Integr Comp Physiol. 2000;278
(6):R1496-R1505.
18. Loftin CD, Trivedi DB, Tiano HF, et al. Failure of ductus
arteriosus closure and remodeling in neonatal mice deficient in
cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci
U S A. 2001;98(3):1059-1064.
19. Thorburn G, ed. The placenta, PGE2 and parturition. In:
Sakamoto S, Takeda Y, eds. Advances in Perinatal Medicine:
Proceedings of the First International Congress on Perinatal Medicine, Tokyo,
5-8 November 1991. Amsterdam, The Netherlands: Elsevier;
1992.
20. Clyman RI, Mauray F, Roman C, Rudolph AM, Heymann MA. Circulating
prostaglandin E2 concentrations and patent ductus arteriosus
in fetal and neonatal lambs. J Pediatr. 1980;97(3):455-461.
21. Clyman RI, Mauray F, Heymann MA, Roman C. Effect of gestational
age on pulmonary metabolism of prostaglandin E1 & E2. Prostaglandins. 1981;21(3):505-513.
22. Sodini D, Baragatti B, Barogi S, Laubach VE, Coceani F.
Indomethacin promotes nitric oxide function in the ductus arteriosus
in the mouse. Br J Pharmacol. 2008;153(8):1631-1640.
23. Fox JJ, Ziegler JW, Dunbar DI, Halbower AC, Kinsella JP,
Abman SH. Role of nitric oxide and cGMP system in regulation of
ductus arteriosus tone in ovine fetus. Am. J. Physiol. 1996;271(2):H2638-H2645.
24. Coceani F, Kelsey L, Seidlitz E, et al. Carbon monoxide
formation in the ductus arteriosus in the lamb: implications for
the regulation of muscle tone. Br J Pharmacol. 1997;120(4):599-608.
25. Friedman WF, Printz MP, Kirkpatrick SE, Hoskins EJ. The
vasoactivity of the fetal lamb ductus arteriosus studied in utero. Pediatr
Res. 1983;17(5):331-337.
26. Momma K, Toyoshima K, Takeuchi D, Imamura S, Nakanishi T.
In vivo constriction of the fetal and neonatal ductus arteriosus
by a prostanoid EP4-receptor antagonist in rats. Pediatr Res. 2005;58(5):971-975.
27. Reese J, Anderson JD, Brown N, Roman C, Clyman RI. Inhibition
of cyclooxygenase isoforms in late- but not midgestation decreases contractility
of the ductus arteriosus and prevents postnatal closure in mice. Am
J Physiol Regul Integr Comp Physiol. 2006;291(6):R1717-R1723.
28. Nguyen M, Camenisch T, Snouwaert JN, et al. The prostaglandin
receptor EP4 triggers remodelling of the cardiovascular system at
birth. Nature. 1997;390(6655):78-81.
29. Baragatti B, Brizzi F, Ackerley C, Barogi S, Ballou LR,
Coceani F. Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus
arteriosus: individual activity and functional coupling with nitric
oxide synthase. Br J Pharmacol. 2003;139(8):1505-1515.
30. Baragatti B, Brizzi F, Barogi S, et al. Interactions between
NO, CO and an endothelium-derived hyperpolarizing factor (EDHF)
in maintaining patency of the ductus arteriosus in the mouse. Br
J Pharmacol. 2007;151(1):54-62.
31. Yokoyama U, Minamisawa S, Quan H, et al. Chronic activation
of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation
in the ductus arteriosus. J Clin Invest. 2006;116(11):3026-3034.
32. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI.
Neonatal complications after the administration of indomethacin
for preterm labor. N Engl J Med. 1993;329(22):1602-1607.
33. Goldbarg SH, Takahashi Y, Cruz C, et al. In utero indomethacin
alters O2 delivery to the fetal ductus arteriosus: implications
for postnatal patency. Am J Physiol Regul Integr Comp Physiol. 2002;282(1):R184-R190.
34. Clyman RI, Chen YQ, Chemtob S, et al. In utero remodeling
of the fetal lamb ductus arteriosus: the role of antenatal indomethacin
and avascular zone thickness on vasa vasorum proliferation, neointima
formation, and cell death. Circulation. 2001;103(13):1806-1812.
35. Abrams SE, Walsh KP, Coker SJ, Clarkson MJ. Responses of
the post-term arterial duct to oxygen, prostaglandin E2, and the
nitric oxide donor, 3-morpholinosydnonimine, in lambs and their
clinical implications. Br Heart J. 1995;73(2):177-181.
36. Clyman RI, Mauray F, Roman C, Heymann MA, Payne B. Factors
determining the loss of ductus arteriosus responsiveness to prostaglandin
E
2.
Circulation. 1983;68:433-436.
[PubMed: 6861319]
37. Fay FS. Guinea pig ductus arteriosus. I. Cellular and metabolic
basis for oxygen sensitivity. Am J Physiol. 1971;221(2):470-479.
38. Roulet MJ, Coburn RF. Oxygen-induced contraction in the
guinea pig neonatal ductus arteriosus. Circ Res. 1981;49(4):997-1002.
39. Reeve HL, Tolarova S, Nelson DP, Archer S, Weir EK. Redox
control of oxygen sensing in the rabbit ductus arteriosus. J
Physiol. 2001;533(Pt 1):253-261.
40. Michelakis E, Rebeyka I, Bateson J, Olley P, Puttagunta
L, Archer S. Voltage-gated potassium channels in human ductus arteriosus. Lancet. 2000;356(9224):134-137.
41. Nakanishi T, Gu H, Hagiwara N, Momma K. Mechanisms of oxygen-induced
contraction of ductus arteriosus isolated from the fetal rabbit. Circ
Res. 1993;72(6):1218-1228.
42. Wu C, Hayama E, Imamura S, Matsuoka R, Nakanishi T. Developmental
changes in the expression of voltage-gated potassium channels in
the ductus arteriosus of the fetal rat. Heart Vessels. 2007;22(1):34-40.
43. Hayama E, Imamura S, Wu C, Nakazawa M, Matsuoka R, Nakanishi
T. Analysis of voltage-gated potassium channel beta1 subunits in
the porcine neonatal ductus arteriosus. Pediatr Res. 2006;59(2):167-174.
44. Thebaud B, Wu XC, Kajimoto H, et al. Developmental absence
of the O2 sensitivity of L-type calcium channels in preterm ductus
arteriosus smooth muscle cells impairs O2 constriction contributing
to patent ductus arteriosus. Pediatr Res. 2008;63(2):176-181.
45. Hong Z, Hong F, Olschewski A, et al. Role of store-operated
calcium channels and calcium sensitization in normoxic contraction
of the ductus arteriosus. Circulation. 2006;114(13):1372-1379.
46. Keck M, Resnik E, Linden B, et al. Oxygen increases ductus
arteriosus smooth muscle cytosolic calcium via release of calcium
from inositol triphosphate-sensitive stores. Am J Physiol
Lung Cell Mol Physiol. 2005;288(5):L917-L923.
47. Kajimoto H, Hashimoto K, Bonnet SN, et al. Oxygen activates
the Rho/Rho-kinase pathway and induces RhoB and ROCK-1
expression in human and rabbit ductus arteriosus by increasing mitochondria-derived
reactive oxygen species. A newly recognized mechanism for sustaining
ductal constriction.
Circulation. 2007;115:1777-1788.
[PubMed: 17353442]
48. Michelakis ED, Rebeyka I, Wu X, et al. O2 sensing in the
human ductus arteriosus: regulation of voltage-gated K+ channels
in smooth muscle cells by a mitochondrial redox sensor. Circ
Res. 2002;91(6):478-486.
49. Clyman RI, Saugstad OD, Mauray F. Reactive oxygen metabolites
relax the lamb ductus arteriosus by stimulating prostaglandin production. Circ
Res. 1989;64(1):1-8.
50. Coceani F, Wright J, Breen C. Ductus arteriosus: involvement
of a sarcolemmal cytochrome P-450 in O2 constriction? Can
J Physiol Pharmacol. 1989;67(11):1448-1450.
51. Coceani F, Kelsey L, Ackerley C, Rabinovitch M, Gelboin
H. Cytochrome P450 during ontogenic development: occurrence in the
ductus arteriosus and other tissues. Can J Physiol Pharmacol. 1994;72(3):217-226.
52. Coceani F, Armstrong C, Kelsey L. Endothelin is a potent
constrictor of the lamb ductus arteriosus. Can J Physiol
Pharmacol. 1989;67(8):902-904.
53. Fineman JR, Takahashi Y, Roman C, Clyman RI. Endothelin-receptor
blockade does not alter closure of the ductus arteriosus. Am
J Physiol. 1998;275(5 Pt 2):H1620-H1626.
54. Taniguchi T, Muramatsu I. Pharmacological knockout of endothelin
ET(A) receptors. Life Sci. 2003;74(2-3):405-409.
55. Shen J, Nakanishi T, Gu H, et al. The role of endothelin
in oxygen-induced contraction of the ductus arteriosus in rabbit
and rat fetuses. Heart Vessels. 2002;16(5):181-188.
56. Smith GC. The pharmacology of the ductus arteriosus. Pharmacol
Rev. 1998;50(1):35-58.
57. Ikeda M, Rubinstein EH, Sonnenschein RR. Interaction of
three factors in the closure of the ductus arteriosus. Proc
Soc Exp Biol Med. 1973;143(2):354-359.
58. Brown S, Liu X-T, Ramaekers F, Rosenfeld C. Differential
maturation in ductus arteriosus and umbilical artery smooth muscle
during ovine development. Pediatr Res. 2002;51:34A.
59. Reeve H, Tolarova S, Cornfield D, Tristani-Firouzi M, Archer
S, Weir E. Developmental changes in K+ channel expression
may determine the O2 response of the ductus arteriosus. FASEB
J. 1997;11:420A.
60. Thebaud B, Michelakis ED, Wu XC, et al. Oxygen-sensitive
Kv channel gene transfer confers oxygen responsiveness to preterm
rabbit and remodeled human ductus arteriosus: implications for infants
with patent ductus arteriosus. Circulation. 2004;110(11):1372-1379.
61. Agren P, Cogolludo AL, Kessels CG, et al. Ontogeny of chicken
ductus arteriosus response to oxygen and vasoconstrictors. Am
J Physiol Regul Integr Comp Physiol. 2007;292(1):R485-R496.
62. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N,
Bancalari E. Influence of infection on patent ductus arteriosus
and chronic lung disease in premature infants weighing 1000 grams
or less. J Pediatr. 1996;128(4):470-478.
63. Clyman RI, Waleh N, Black SM, Riemer RK, Mauray F, Chen
YQ. Regulation of ductus arteriosus patency by nitric oxide in fetal
lambs. The role of gestation, oxygen tension and vasa vasorum.
Pediatr
Res. 1998;43:633-644.
[PubMed: 9585010]
64. Waleh N, Kajino H, Marrache AM, et al. Prostaglandin E2–mediated
relaxation of the ductus arteriosus: effects of gestational age
on g protein-coupled receptor expression, signaling, and vasomotor
control. Circulation. 2004;110(16):2326-2332.
65. Liu H, Manganiello VC, Clyman RI. Expression, activity and
function of cAMP and cGMP phosphodiesterases in the mature and immature ductus
arteriosus. Pediatr Res. 2008;64(5):477-481.
66. Seidner SR, Chen Y-Q, Oprysko PR, et al. Combined prostaglandin
and nitric oxide inhibition produces anatomic remodeling and closure
of the ductus arteriosus in the premature newborn baboon. Pediatr
Res. 2001;50(3):365-373.
67. Takami T, Yoda H, Kawakami T, et al. Usefulness of indomethacin
for patent ductus arteriosus in full-term infants.
Pediatr
Cardiol. 2007; 28(1):46-50.
[PubMed: 17203336]
68. Wu GR, Jing S, Momma K, Nakanishi T. The effect of vitamin
A on contraction of the ductus arteriosus in fetal rat. Pediatr
Res. 2001;49(6):747-754.
69. Ravishankar C, Nafday S, Green RS, et al. A trial of vitamin
A therapy to facilitate ductal closure in premature infants. J
Pediatr. 2003;143(5):644-648.
70. Clyman RI, Mauray F, Roman C, et al. Effects of antenatal
glucocorticoid administration on the ductus arteriosus of preterm
lambs. Am J Physiol. 1981;241:H415-H420.
71. Collaborative Group on Antenatal Steroid Therapy. Prevention
of respiratory distress syndrome: effect of antenatal
dexamethasone administration.
Publication No 85-2695: National Institutes of Health; 1985:44.
72. Clyman RI, Ballard PL, Sniderman S, et al. Prenatal administration
of
betamethasone for prevention of patent ductus arteriosus.
J
Pediatr. 1981;98(1):123-126.
73. Momma K, Mishihara S, Ota Y. Constriction of the fetal ductus
arteriosus by glucocorticoid hormones. Pediatr Res. 1981;15(1):19-21.
74. Thibeault DW, Emmanouilides GC, Dodge ME. Pulmonary and
circulatory function in preterm lambs treated with
hydrocortisone
in utero.
Biol Neonate. 1978;34(5-6):238-247.
75. Waffarn F, Siassi B, Cabal L, Schmidt PL. Effect of antenatal
glucocorticoids on clinical closure of the ductus arteriosus. Am
J Dis Child. 1983;137(4):336-338.
76. Group VONSS. Early postnatal
dexamethasone therapy for the
prevention of chronic lung disease.
Pediatrics. 2001;108(3):741-748.
77. Watterberg KL, Gerdes JS, Cole CH, et al. Prophylaxis of
early adrenal insufficiency to prevent bronchopulmonary dysplasia:
a multicenter trial. Pediatrics. 2004;114(6):1649-1657.
78. Bodach E, Coceani F, Dumbrille A, Okpako DT, Olley PM. The
response of the isolated ductus arteriosus to transmural stimulation
and drugs. Br J Pharmacol. 1980;71(2):419-427.
79. Dzialowski EM, Greyner H. Maturation of the contractile
response of the emu ductus arteriosus. J Comp Physiol [B]. 2008;178(3):401-412.
80. Bergwerff M, Gittenberger-de Groot AC, Wisse LJ, et al.
Loss of function of the Prx1 and Prx2 homeobox genes alters architecture
of the great elastic arteries and ductus arteriosus. Virchows Arch. 2000;436(1):12-19.
81. Morano I, Chai GX, Baltas LG, et al. Smooth-muscle contraction
without smooth-muscle myosin. Nat Cell Biol. 2000;2(6):371-375.
82. Segi E, Sugimoto Y, Yamasaki A, et al. Patent ductus arteriosus
and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys
Res Commun. 1998;246(1):7-12.
83. Huang GY, Wessels A, Smith BR, Linask KK, Ewart JL, Lo CW.
Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart
development. Dev Biol. 1998;198(1):32-44.
84. Zhao F, Weismann CG, Satoda M, et al. Novel TFAP2B mutations
that cause Char syndrome provide a genotype-phenotype correlation. Am J
Hum Genet. 2001;69(4):695-703.
85. Pannu H, Tran-Fadulu V, Papke CL, et al. MYH11 mutations
result in a distinct vascular pathology driven by insulin-like growth
factor 1 and angiotensin II. Hum Mol Genet. 2007;16(20):2453-2462.
86. Treszl A, Szabo M, Dunai G, et al. Angiotensin II type 1
receptor A1166C polymorphism and prophylactic indomethacin treatment
induced ductus arteriosus closure in very low birth weight neonates. Pediatr
Res. 2003;54(5):753-755.
87. Treszl A, Kaposi A, Hajdu J, Szabo M, Tulassay T, Vasarhelyi
B. The extent to which genotype information may add to the prediction
of disturbed perinatal adaptation: none, minor, or major? Pediatr
Res. 2007;62(5):610-614.
88. Fox JW, Lamperti ED, Eksioglu YZ, et al. Mutations in filamin
1 prevent migration of cerebral cortical neurons in human periventricular
heterotopia. Neuron. 1998;21(6):1315-1325.
89. Mason CA, Bigras JL, O’Blenes SB, et al. Gene transfer
in utero biologically engineers a patent ductus arteriosus in lambs
by arresting fibronectin-dependent neointimal formation. Nat
Med. 1999;5(2):176-182.
90. Jarkovska D, Janatova T, Hruda J, Ostadal B, Samanek M.
Effect of prostaglandin E2 on the ductus arteriosus in the newborn
rat. An ultrastructural study. Physiol Res. 1992;41(4):323-330.
91. Fay FS, Cooke PH. Guinea pig ductus arteriosus. II. Irreversible
closure after birth. Am J Physiol. 1972;222(4):841-849.
92. Clyman RI, Chan CY, Mauray F, et al. Permanent anatomic
closure of the ductus arteriosus in newborn baboons: the roles of
postnatal constriction, hypoxia, and gestation. Pediatr Res. 1999;45(1):
19-29.
93. Kajino H, Goldbarg S, Roman C, et al. Vasa vasorum hypoperfusion
is responsible for medial hypoxia and anatomic remodeling in the
newborn lamb ductus arteriosus. Pediatr Res. 2002;51(2):228-235.
94. Clyman RI, Seidner SR, Kajino H, et al. VEGF regulates remodeling
during permanent anatomic closure of the ductus arteriosus. Am
J Physiol. 2002;282(1):R199-R206.
95. Waleh N, Seidner S, McCurnin D, et al. The role of monocyte-derived
cells and inflammation in baboon ductus arteriosus remodeling. Pediatr
Res. 2005;57(2):254-262.
96. Guerguerian A-M, Hardy P, Bhattacharya M, et al. Expression
of cyclooxygenases in ductus arteriosus of fetal and newborn pigs. Am
J Obstet Gynecol. 1998;179(6):1618-1626.
97. Levin M, Goldbarg S, Lindqvist A, et al. ATP depletion and
cell death in the neonatal lamb ductus arteriosus. Pediatr
Res. 2005;57(6):801-805.
98. Clyman RI. Commentary: recommendations for the postnatal
use of indomethacin. An analysis of four separate treatment strategies.
J Pediatr. 1996;128:601-607.
[PubMed: 8627430]
99. Schmidt B, Davis P, Moddemann D, et al. Long-term effects
of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl
J Med. 2001;344(26):1966-1972.
100. Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV,
Clyman RI. Combined treatment with a non-selective nitric oxide
synthase inhibitor (L-NMMA) and indomethacin increases ductus constriction
in extremely premature newborns.
Pediatr Res. 2005;58:1216-1221.
[PubMed: 16306196]
101. Clyman RI, Mauray F, Heymann MA, Roman C. Cardiovascular
effects of a patent ductus arteriosus in preterm lambs with respiratory distress.
J
Pediatr. 1987;111:579-587.
[PubMed: 3655990]
102. Al Faleh K, Smyth J, Roberts R, Solimano A, Asztalos E,
Schmidt B. Prevention and 18-month outcome of serious pulmonary
hemorrhage in extremely low birth weight infants: results from the
trial of indomethacin prophylaxis in preterms. Pediatrics. 2008;121(2):e233-e238.
103. McCurnin DC, Seidner S, Chang LY, et al. Ibuprofen-induced
ductus arteriosus closure: physiological, histological and biochemical
effects on the premature lung. Pediatrics. 2008;5(121):945-956.
104. Cotton RB, Stahlman MT, Berder HW, Graham TP, Catterton
WZ, Kover I. Randomized trial of early closure of symptomatic patent ductus
arteriosus in small preterm infants.
J Pediatr. 1978;93:647-651.
[PubMed: 702245]
105. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L.
Severity of the ductal shunt: a comparison of different markers. Arch
Dis Child Fetal Neonatal Ed. 2005;90(5):F419-F422.
106. El-Khuffash A, Molloy EJ. Are B-type natriuretic peptide
(BNP) and N-terminal-pro-BNP useful in neonates? Arch Dis
Child Fetal Neonatal Ed. 2007;92(4):F320-F324.
107. Chorne N, Jegatheesan P, Lin E, Shi R, Clyman RI. Risk
factors for persistent ductus arteriosus patency during indomethacin
treatment. J Pediatr. 2007;151(6):629-634.
108. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment
with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus
in preterm infants. Cohrane Database Syst Rev 2008 Jan 23; CD003951.
109. Ment LR, Vohr BR, Makuch RW, et al. Prevention of intraventricular
hemorrhage by indomethacin in male preterm infants. J Pediatr. 2004;145(6):832-834.
110. Kiserud T. Physiology of the fetal circulation. Semin
Fetal Neonatal Med. 2005;10(6):493-503.
111. Adeagbo AS, Kelsey L, Coceani F. Endothelin-induced constriction
of the ductus venosus in fetal sheep: developmental aspects and
possible interaction with vasodilatory prostaglandin. Br
J Pharmacol. 2004;142(4):727-736.
112.Adeagbo ASO, Coceani F, Olley PM. The response of the lamb
ductus venosus to prostaglandins and inhibitors of prostaglandin
and throboxane synthesis.
Circ Res. 1982;51:580-586.
[PubMed: 6754125]
113. Adeagbo AS, Breen CA, Cutz E, Lees JG, Olley PM, Coceani
F. Lamb ductus venosus: evidence of a cytochrome P-450 mechanism
in its contractile tension.
J Pharmacol Exp Ther. 1990;
252(2):875-879.
[PubMed: 2313604]
114. Kiserud T, Ozaki T, Nishina H, Rodeck C, Hanson MA. Effect
of NO,
phenylephrine, and hypoxemia on ductus venosus diameter in
fetal sheep.
Am J Physiol Heart Circ Physiol. 2000; 279(3):H1166-H1171.
115. Tchirikov M, Kertschanska S, Schroder HJ. Differential
effects of catecholamines on vascular rings from ductus venosus
and intrahepatic veins of fetal sheep. J Physiol. 2003;548(Pt
2):519-526.
116. Walisser JA, Bunger MK, Glover E, Bradfield CA. Gestational
exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc
Natl Acad Sci U S A. 2004;101(47):16677-16682.
117. Kondo M, Itoh S, Kunikata T, et al. Time of closure of
ductus venosus in term and preterm neonates. Arch Dis Child
Fetal Neonatal Ed. 2001;85(1):F57-F59.
118. Murayama K, Nagasaka H, Tate K, et al. Significant correlations
between the flow volume of patent ductus venosus and early neonatal liver
function: possible involvement of patent ductus venosus in postnatal
liver function. Arch Dis Child Fetal Neonatal Ed. 2006;91(3):F175-F179.